Cargando…

Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com

Aim: Although some sex differences in stroke have been reported, differences in the effects of antiplatelet therapy for secondary stroke prevention have not been clarified. Methods: In the Cilostazol Stroke Prevention Study combination trial, patients with high-risk, non-cardioembolic ischemic strok...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoshino, Haruhiko, Toyoda, Kazunori, Omae, Katsuhiro, Takahashi, Kaito, Uchiyama, Shinichiro, Kimura, Kazumi, Yamaguchi, Keiji, Minematsu, Kazuo, Origasa, Hideki, Yamaguchi, Takenori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244066/ https://www.ncbi.nlm.nih.gov/pubmed/36070920 http://dx.doi.org/10.5551/jat.63660

Ejemplares similares

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial
por: Toyoda, Kazunori, et al.
Publicado: (2015)

Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis
por: Toyoda, Kazunori, et al.
Publicado: (2022)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

On Singleton Arc Consistency for CSPs Defined by Monotone Patterns
por: Carbonnel, Clément, et al.
Publicado: (2018)

Chemosensory Proteins (CSPs) in the Cotton Bollworm Helicoverpa armigera
por: Agnihotri, Aniruddha, et al.
Publicado: (2021)

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
por: Uchiyama, Shinichiro, et al.
Publicado: (2015)

Communications, signal processing, and systems: proceedings of the 2018 CSPS volume III systems
por: Liang, Qilian, et al.
Publicado: (2019)

Cultural Adaptation and Reliability of the Compliance with Standard Precautions Scale (CSPS) for Nurses in Brazil
por: Pereira, Fernanda Maria Vieira, et al.
Publicado: (2017)

Japanese and Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: A Five-Year Risk Analysis of Stroke and Vascular Events
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study
por: Seo, Woo‐Keun, et al.
Publicado: (2021)

Communications, signal processing, and systems: proceedings of the 2018 CSPS volume II signal processing
por: Liang, Qilian, et al.
Publicado: (2019)

Recurrent CSPs after Transcranial Magnetic Stimulation of Motor Cortex in Restless Legs Syndrome
por: Ahlgrén-Rimpiläinen, Aulikki, et al.
Publicado: (2012)

Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study
por: Kimura, Teruo, et al.
Publicado: (2016)

Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease
por: Hong, Sangmo, et al.
Publicado: (2022)

Achiral Molecular Recognition of Aromatic Position Isomers by Polysaccharide-Based CSPs in Relation to Chiral Recognition
por: Shibata, Tohru, et al.
Publicado: (2016)

Genome-Wide Analysis of Chemosensory Protein Genes (CSPs) Family in Fig Wasps (Hymenoptera, Chalcidoidea)
por: Xin, Zhaozhe, et al.
Publicado: (2020)

Long-Term Effect of Pravastatin on Carotid Intima–Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke)
por: Koga, Masatoshi, et al.
Publicado: (2018)

Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS
por: Kitagawa, Kazuo, et al.
Publicado: (2017)

Rivaroxaban administration after acute ischemic stroke: The RELAXED study
por: Yasaka, Masahiro, et al.
Publicado: (2019)

Neurite Outgrowth Mediated by Translation Elongation Factor eEF1A1: A Target for Antiplatelet Agent Cilostazol
por: Hashimoto, Kenji, et al.
Publicado: (2011)

Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study
por: Wada, Shinichi, et al.
Publicado: (2018)

Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors
por: Byun, Sungwook, et al.
Publicado: (2022)

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
por: Hosomi, Naohisa, et al.
Publicado: (2015)

Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)
por: Yamasaki, Yoshimitsu, et al.
Publicado: (2006)

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA
por: Kitagawa, Kazuo, et al.
Publicado: (2019)

Comparative genomics of chemosensory protein genes (CSPs) in twenty-two mosquito species (Diptera: Culicidae): Identification, characterization, and evolution
por: Mei, Ting, et al.
Publicado: (2018)

Compliance with Standard Precautions among Clinical Nurses: Validity and Reliability of the Italian Version of the Compliance with Standard Precautions Scale (CSPS-It)
por: Donati, Daniele, et al.
Publicado: (2019)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS)
por: Nagai, Yoji, et al.
Publicado: (2014)

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
por: Wang, Mei, et al.
Publicado: (2015)

Cold-Shock Domain Family Proteins (Csps) Are Involved in Regulation of Virulence, Cellular Aggregation, and Flagella-Based Motility in Listeria monocytogenes
por: Eshwar, Athmanya K., et al.
Publicado: (2017)

Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event
por: Hosomi, Naohisa, et al.
Publicado: (2018)

Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study
por: Nezu, Tomohisa, et al.
Publicado: (2020)

Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARS
por: Hosomi, Naohisa, et al.
Publicado: (2020)

Transdermal System Based on Solid Cilostazol Nanoparticles Attenuates Ischemia/Reperfusion-Induced Brain Injury in Mice
por: Otake, Hiroko, et al.
Publicado: (2021)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Adjunctive Cilostazol to Dual Antiplatelet Therapy to Enhance Mobilization of Endothelial Progenitor Cell in Patients with Acute Myocardial Infarction: A Randomized, Placebo-Controlled EPISODE Trial
por: Park, Yongwhi, et al.
Publicado: (2020)

Cilostazol combined with P2Y(12) receptor inhibitors: A substitute antiplatelet regimen for aspirin‐intolerant patients undergoing percutaneous coronary stent implantation
por: Zhao, Yikai, et al.
Publicado: (2022)

Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database
por: Noh, Yoojin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8u2i01oe4rualn6e0hdjqgldms